Evidence map›Paper›PMID 38136378›Full record

ReviewCancers2023

Nodal Elective Volume Selection and Definition during Radiation Therapy for Early Stage (T1-T2 N0 M0) Perianal Squamous Cell Carcinoma: A Narrative Clinical Review and Critical Appraisal.

Lavinia Spinelli, Stefania Martini, Salvatore Dario Solla, Riccardo Vigna Taglianti, Francesco Olivero, Luca Gianello, Alessia Reali, Anna Maria Merlotti, Pierfrancesco Franco

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Innovative radiotherapy approaches.ESMO gastrointestinal oncology · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lavinia SpinelliRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Stefania MartiniRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Salvatore Dario SollaRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Riccardo Vigna TagliantiRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Francesco OliveroRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Luca GianelloRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Alessia RealiRadiation Oncology Department, Michele and Pietro Ferrero Hospital, 12060 Verduno, Italy.
Anna Maria MerlottiRadiation Oncology Department, Santa Croce and Carle Hospital, 12100 Cuneo, Italy.
Pierfrancesco FrancoDepartment of Translational Medicine (DIMET), University of Eastern Piedmont, 28100 Novara, Italy.ORCID 0000-0003-2276-0687
Ospedale San Pietro Fatebenefratelli · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Distinction between anal canal and perianal squamous cell carcinomas (pSCCs) is essential, as these two subgroups have different anatomical, histological, and lymphatic drainage features. Early-stage true perianal tumors are very uncommon and have been rarely included in clinical trials. Perianal skin cancers and aCCs are included in the same tumor classification, even though they have different lymphatic drainage features. Furthermore, pSCCs are treated similarly to carcinomas originating from the anal canal. Radiation therapy (RT) is an essential treatment for anal canal tumors. Guidelines do not differentiate between treatment volumes for perianal tumors and anal cancers. So far, in pSCC, no study has considered modulating treatment volume selection according to the stage of the disease. We conducted a narrative literature review to describe the sites at higher risk for microscopic disease in patients with early-stage perianal cancers (T1-T2 N0 M0) to propose a well-thought selection of RT elective volumes.

Indexed as

anal cancercontouringnarrative reviewperianal squamous cell carcinomaradiotherapytreatment volumes

Identifiers

PMID38136378
PMCPMC10741760
OpenAlexW4389742042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.